The RIO Trial’s Viral Rebound Data Just Complicated Every HIV Functional Cure Strategy on the Market
Phase 2 RIO trial shows 3BNC117-LS and 10-1074-LS delay HIV viral rebound after treatment interruption, but resistance patterns raise...
broadly neutralizing antibodies